321 related articles for article (PubMed ID: 34124163)
1. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma.
Xu Q; Hu Y; Chen S; Zhu Y; Li S; Shen F; Guo Y; Sun T; Chen X; Jiang J; Huang W
Front Mol Biosci; 2021; 8():683240. PubMed ID: 34124163
[No Abstract] [Full Text] [Related]
2. Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
Cancer Cell Int; 2021 Apr; 21(1):190. PubMed ID: 33794886
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Wang Z; Li N; Qi Z; Zhao J; Huang W
Cancer Cell Int; 2021 Jul; 21(1):342. PubMed ID: 34217320
[TBL] [Abstract][Full Text] [Related]
4. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
5. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
6. Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy.
Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
Front Cell Dev Biol; 2021; 9():669145. PubMed ID: 34422799
[No Abstract] [Full Text] [Related]
7. Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma.
Xu Q; Chen S; Hu Y; Huang W
Front Genet; 2021; 12():739975. PubMed ID: 34589117
[No Abstract] [Full Text] [Related]
8. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
9. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma.
Xu Q; Chen S; Hu Y; Huang W
Cancer Cell Int; 2021 Oct; 21(1):582. PubMed ID: 34717651
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma.
He C; Guo Z; Zhang H; Yang G; Gao J; Mo Z
Aging (Albany NY); 2024 Jan; 16(2):1733-1749. PubMed ID: 38244582
[TBL] [Abstract][Full Text] [Related]
11. Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures.
Zhang J; Jiang H; Rao D; Jin X
Front Oncol; 2023; 13():1206882. PubMed ID: 38288096
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma.
Hu Y; Liu J; Yu J; Yang F; Zhang M; Liu Y; Ma S; Zhou X; Wang J; Han Y
Cancer Cell Int; 2022 Feb; 22(1):97. PubMed ID: 35193632
[TBL] [Abstract][Full Text] [Related]
13. Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.
Wang J; Ling S; Ni J; Wan Y
BMC Cancer; 2022 Jun; 22(1):638. PubMed ID: 35681134
[TBL] [Abstract][Full Text] [Related]
14. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
Front Genet; 2023; 14():1025163. PubMed ID: 36911389
[No Abstract] [Full Text] [Related]
15. Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular Carcinoma.
Chen J; Zhang L; Lu CH; Xu CZ
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38213141
[TBL] [Abstract][Full Text] [Related]
16. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients.
Fu J; Qin W; Tong Q; Li Z; Shao Y; Liu Z; Liu C; Wang Z; Xu X
Cancer Med; 2022 Dec; 11(23):4721-4735. PubMed ID: 35637633
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
18. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma.
Li R; Shui L; Jia J; Wu C
Front Genet; 2020; 11():906. PubMed ID: 32922438
[TBL] [Abstract][Full Text] [Related]
20. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
Xu Q; Chen S; Hu Y; Huang W
Front Immunol; 2021; 12():711433. PubMed ID: 34512634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
